Henri Desmolin

Title: The Innovative Mind of Henri Desmolin

Introduction

Henri Desmolin, an accomplished inventor based in Merignac, France, has made significant strides in the realm of pharmaceutical innovations. With a total of three patents to his name, Desmolin has contributed valuable insights and technologies aimed at improving medication efficacy and patient care.

Latest Patents

Among his latest inventions are groundbreaking patents focused on sustained-release microbeads of diltiazem. These microbeads are designed with a core that contains the active ingredient, enveloped in a microporous membrane made from a film-forming polymer. This innovative membrane is insoluble in aqueous mediums and facilitates a steady release of diltiazem over a period of at least six hours after a quick latent phase. The microbeads can be produced using a method involving the application of a dispersion of membrane constituents onto the core followed by solvent evaporation. Additionally, he has developed a new pharmaceutical composition based on valproic acid, aimed at enhancing the production and bioavailability of medications through an improved galenic preparation process.

Career Highlights

Desmolin has showcased his expertise while working at prominent companies such as Sanofi and Elf Sanofi. His contributions to the pharmaceutical field have laid the groundwork for advancements in medication formulations, particularly in terms of sustained release systems.

Collaborations

Throughout his career, Henri Desmolin has collaborated with notable colleagues, including Daniel Aubert and Francis Blanc. These partnerships have been instrumental in fostering innovation and driving the progress of their shared projects.

Conclusion

Henri Desmolin's inventive spirit and contributions to pharmaceutical science make him a noteworthy figure in the field of innovations and inventions. His novel approaches to drug formulation continue to have a positive impact on patient treatment protocols and medication management.